Hypothalamic Neoplasms: Clinical Trials

5 trials for Hypothalamic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow Hypothalamic Neoplasms: new trials by email Literature Review of Hypothalamic Neoplasms trials Research Report on Hypothalamic Neoplasms

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform - Pituitary Tumor, Pituitary Adenoma
Phase 1CompletedUniversity Medical Center Groningen202020-10-282023-04-14
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Photofrin (porfimer sodium) & photodynamic therapy. - Brain Tumor, Recurrent
Phase 1CompletedHarry T Whelan, MD52013-03-012019-02-25
Fluorescence Guided Resection of Brain Tumors
5-aminolevulinic acid - Brain Tumors
Phase 1CompletedDavid W. Roberts1052007-05-012019-06-14
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
entinostat - Cancer
Phase 1CompletedNational Institutes of Health Clinical Center (CC)752001-03-012012-03-15
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
yttrium Y 90-edotreotide - Brain and Central Nervous System Tumors, Breast Cancer
Phase 1CompletedNovartis Pharmaceuticals601998-01-012013-05-01

Narrower conditions

Pituitary Neoplasms (5)  ·  Brain Neoplasms (4)  ·  Meningioma (4)  ·  Astrocytoma (3)  ·  Craniopharyngioma (3)  ·  Ependymoma (3)  ·  Glioma (3)  ·  Glioma, Subependymal (3)  ·  Medulloblastoma (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Oligodendroglioma (3)  ·  Breast Neoplasms (2)  ·  Burkitt Lymphoma (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Choroid Plexus Neoplasms (2)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Endocrine Gland Neoplasms (5)  ·  Endocrine System Diseases (5)  ·  Hypothalamic Diseases (5)  ·  Neoplasms by Site (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Pituitary Diseases (5)  ·  Supratentorial Neoplasms (5)  ·  Central Nervous System Neoplasms (4)  ·  Meningeal Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)

Interventions

90Y-octreotide, DOTA-Tyr(3)- (1)  ·  Aminolevulinic Acid (1)  ·  Dihematoporphyrin Ether (1)  ·  Photochemotherapy (1)  ·  entinostat (1)

Sponsors

David W. Roberts (1)  ·  Harry T Whelan, MD (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Novartis Pharmaceuticals (1)  ·  University Medical Center Groningen (1)

Countries

United States (4)  ·  Netherlands (1)

Top investigators

David W Roberts, MD (1)  ·  Harry T Whelan, MD (1)  ·  Jeff Knipstein, MD (1)  ·  Keith Paulsen, PhD (1)  ·  Larry K. Kvols, MD (1)  ·  Shivaani Kummar, MD (1)

Results publications

PMID 34620658, PMID 39390132

NIH funding

R01NS052274 (1)